News
This colourized electron microscope image provided by the National Institute of Allergy and Infectious Diseases in 2024 shows mpox virus particles, green, found within infected cultured cells ...
A new case of the latest Mpox strain has been detected in England in a person with no travel history or links to any of the other cases - sparking fears the virus could be silently sweeping across ...
Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists. Mpox has the potential to become a significant global health threat if taken too ...
Mpox is a viral infection caused by a virus that belongs to the same family as smallpox. The virus can cause a painful rash, fever, and swollen glands and, in some cases, lead to more serious ...
Pakistan confirmed the second case of mpox this year when a 29-year-old man tested positive for the contagious viral infection in Karachi, according to a media report. The patient, a resident of Shah ...
placebo. Other antivirals against mpox are under development, researchers said. SAN FRANCISCO — Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in ...
The United Kingdom has identified another case of a contagious new strain of mpox, making it the latest European country to report an infection. The new strain has infected thousands of people in ...
MPOX has the potential to become a significant global threat if international action isn't taken now, warn scientists. Mpox is a viral infection caused by a virus that belongs to the same family ...
The National Medical Products Administration, China's top drug regulator, approved the vaccine for clinical trials in ...
Since eradicating smallpox, only rare outbreaks of related viruses appeared. But today, mpox, once confined mainly to rural parts of Africa, is spreading globally, and the reasons behind this ...
It has been approved for use against Mpox in the USA and Canada for several years under the names Jynneos and Imvamune. It is a live-attenuated vaccine that contains viruses incapable of ...
China's first mpox vaccine candidate has begun Phase I clinical trials, the Shanghai Institute of Biological Products Co said on Tuesday. Medical experts said the vaccine could play a crucial role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results